民生銀行(01988.HK)與大家人壽簽訂金融產品代理銷售業務合作框架協議
格隆匯12月11日丨民生銀行(01988.HK)發佈公告,董事會於2019年12月11日審議批准了《關於大家保險集團有限責任公司2019年度集團統一授信的議案》,授信主體包括大家保險集團有限責任公司及其關聯方。在經董事會審議批准的本次集團統一授信代理類非授信業務預留額度內,公司將適時與大家保險集團有限責任公司的附屬公司大家人壽簽署金融產品代理銷售業務合作框架協議。
公告表示,為了積極適應零售市場變化,公司與大家人壽的合作有助於公司拓寬個人客户產品供應範圍,同時與大家人壽實現資源共享、優勢互補,從而進一步提升公司零售業務中間業務收入規模。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.